Cargando…

Imaging features of small vessel disease in cerebral amyloid angiopathy among patients with Alzheimer’s disease

BACKGROUND AND PURPOSE: Cerebral small vessel disease biomarkers including white matter hyperintensities (WMH), lacunes, and enlarged perivascular spaces (ePVS) are under investigation to identify those specific to cerebral amyloid angiopathy (CAA). In subjects with Alzheimer’s disease (AD), we asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagaraja, Nandakumar, DeKosky, Steven, Duara, Ranjan, Kong, Lan, Wang, Wei-en, Vaillancourt, David, Albayram, Mehmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236212/
https://www.ncbi.nlm.nih.gov/pubmed/37245492
http://dx.doi.org/10.1016/j.nicl.2023.103437
_version_ 1785052865499234304
author Nagaraja, Nandakumar
DeKosky, Steven
Duara, Ranjan
Kong, Lan
Wang, Wei-en
Vaillancourt, David
Albayram, Mehmet
author_facet Nagaraja, Nandakumar
DeKosky, Steven
Duara, Ranjan
Kong, Lan
Wang, Wei-en
Vaillancourt, David
Albayram, Mehmet
author_sort Nagaraja, Nandakumar
collection PubMed
description BACKGROUND AND PURPOSE: Cerebral small vessel disease biomarkers including white matter hyperintensities (WMH), lacunes, and enlarged perivascular spaces (ePVS) are under investigation to identify those specific to cerebral amyloid angiopathy (CAA). In subjects with Alzheimer’s disease (AD), we assessed characteristic features and amounts of WMH, lacunes, and ePVS in four CAA categories (no, mild, moderate and severe CAA) and correlated these with Clinical Dementia Rating sum of boxes (CDRsb) score, ApoE genotype, and neuropathological changes at autopsy. METHODS: The study included patients with a clinical diagnosis of dementia due to AD and neuropathological confirmation of AD and CAA in the National Alzheimer’s Coordinating Center (NACC) database. The WMH, lacunes, and ePVS were evaluated using semi-quantitative scales. Statistical analyses compared the WMH, lacunes, and ePVS values in the four CAA groups with vascular risk factors and AD severity treated as covariates, and to correlate the imaging features with CDRsb score, ApoE genotype, and neuropathological findings. RESULTS: The study consisted of 232 patients, of which 222 patients had FLAIR data available and 105 patients had T2-MRI. Occipital predominant WMH were significantly associated with the presence of CAA (p = 0.007). Among the CAA groups, occipital predominant WMH was associated with severe CAA (β = 1.22, p = 0.0001) compared with no CAA. Occipital predominant WMH were not associated with the CDRsb score performed at baseline (p = 0.68) or at follow-up 2–4 years after the MRI (p = 0.92). There was no significant difference in high grade ePVS in the basal ganglia (p = 0.63) and centrum semiovale (p = 0.95) among the four CAA groups. The WMH and ePVS on imaging did not correlate with the number of ApoE ε4 alleles but the WMH (periventricular and deep) correlated with the presence of infarcts, lacunes and microinfarcts on neuropathology. CONCLUSION: Among patients with AD, occipital predominant WMH is more likely to be found in patients with severe CAA than in those without CAA. The high-grade ePVS in centrum semiovale were common in all AD patients regardless of CAA severity.
format Online
Article
Text
id pubmed-10236212
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102362122023-06-03 Imaging features of small vessel disease in cerebral amyloid angiopathy among patients with Alzheimer’s disease Nagaraja, Nandakumar DeKosky, Steven Duara, Ranjan Kong, Lan Wang, Wei-en Vaillancourt, David Albayram, Mehmet Neuroimage Clin Regular Article BACKGROUND AND PURPOSE: Cerebral small vessel disease biomarkers including white matter hyperintensities (WMH), lacunes, and enlarged perivascular spaces (ePVS) are under investigation to identify those specific to cerebral amyloid angiopathy (CAA). In subjects with Alzheimer’s disease (AD), we assessed characteristic features and amounts of WMH, lacunes, and ePVS in four CAA categories (no, mild, moderate and severe CAA) and correlated these with Clinical Dementia Rating sum of boxes (CDRsb) score, ApoE genotype, and neuropathological changes at autopsy. METHODS: The study included patients with a clinical diagnosis of dementia due to AD and neuropathological confirmation of AD and CAA in the National Alzheimer’s Coordinating Center (NACC) database. The WMH, lacunes, and ePVS were evaluated using semi-quantitative scales. Statistical analyses compared the WMH, lacunes, and ePVS values in the four CAA groups with vascular risk factors and AD severity treated as covariates, and to correlate the imaging features with CDRsb score, ApoE genotype, and neuropathological findings. RESULTS: The study consisted of 232 patients, of which 222 patients had FLAIR data available and 105 patients had T2-MRI. Occipital predominant WMH were significantly associated with the presence of CAA (p = 0.007). Among the CAA groups, occipital predominant WMH was associated with severe CAA (β = 1.22, p = 0.0001) compared with no CAA. Occipital predominant WMH were not associated with the CDRsb score performed at baseline (p = 0.68) or at follow-up 2–4 years after the MRI (p = 0.92). There was no significant difference in high grade ePVS in the basal ganglia (p = 0.63) and centrum semiovale (p = 0.95) among the four CAA groups. The WMH and ePVS on imaging did not correlate with the number of ApoE ε4 alleles but the WMH (periventricular and deep) correlated with the presence of infarcts, lacunes and microinfarcts on neuropathology. CONCLUSION: Among patients with AD, occipital predominant WMH is more likely to be found in patients with severe CAA than in those without CAA. The high-grade ePVS in centrum semiovale were common in all AD patients regardless of CAA severity. Elsevier 2023-05-17 /pmc/articles/PMC10236212/ /pubmed/37245492 http://dx.doi.org/10.1016/j.nicl.2023.103437 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Nagaraja, Nandakumar
DeKosky, Steven
Duara, Ranjan
Kong, Lan
Wang, Wei-en
Vaillancourt, David
Albayram, Mehmet
Imaging features of small vessel disease in cerebral amyloid angiopathy among patients with Alzheimer’s disease
title Imaging features of small vessel disease in cerebral amyloid angiopathy among patients with Alzheimer’s disease
title_full Imaging features of small vessel disease in cerebral amyloid angiopathy among patients with Alzheimer’s disease
title_fullStr Imaging features of small vessel disease in cerebral amyloid angiopathy among patients with Alzheimer’s disease
title_full_unstemmed Imaging features of small vessel disease in cerebral amyloid angiopathy among patients with Alzheimer’s disease
title_short Imaging features of small vessel disease in cerebral amyloid angiopathy among patients with Alzheimer’s disease
title_sort imaging features of small vessel disease in cerebral amyloid angiopathy among patients with alzheimer’s disease
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236212/
https://www.ncbi.nlm.nih.gov/pubmed/37245492
http://dx.doi.org/10.1016/j.nicl.2023.103437
work_keys_str_mv AT nagarajanandakumar imagingfeaturesofsmallvesseldiseaseincerebralamyloidangiopathyamongpatientswithalzheimersdisease
AT dekoskysteven imagingfeaturesofsmallvesseldiseaseincerebralamyloidangiopathyamongpatientswithalzheimersdisease
AT duararanjan imagingfeaturesofsmallvesseldiseaseincerebralamyloidangiopathyamongpatientswithalzheimersdisease
AT konglan imagingfeaturesofsmallvesseldiseaseincerebralamyloidangiopathyamongpatientswithalzheimersdisease
AT wangweien imagingfeaturesofsmallvesseldiseaseincerebralamyloidangiopathyamongpatientswithalzheimersdisease
AT vaillancourtdavid imagingfeaturesofsmallvesseldiseaseincerebralamyloidangiopathyamongpatientswithalzheimersdisease
AT albayrammehmet imagingfeaturesofsmallvesseldiseaseincerebralamyloidangiopathyamongpatientswithalzheimersdisease